Concentra Group Holdings Parent (CON) Stock Price, News & Analysis

Company Overview

Concentra Group Holdings Parent (NYSE:CON) is a Canada-based financial services holding company that specializes in serving Canadian credit unions and their members. Through its operating subsidiaries, the group provides wholesale funding, lending solutions and investment management services tailored to the unique needs of cooperative financial institutions. Concentra’s broad suite of offerings includes trust and custody services, mortgage investment products and equipment financing, all designed to support credit-union growth and stability.

In addition to wholesale funding and lending, Concentra Group Holdings Parent distributes life and general insurance products through affiliated insurance brokers and credit-union channels. The company also offers retail investment solutions such as mortgage investment corporations (MICs), pooled asset portfolios and managed accounts for individual investors. By combining institutional expertise with local delivery through a network of credit unions, Concentra helps enhance access to diversified financial products across Canada.

Founded in 1977 and headquartered in Saskatoon, Saskatchewan, Concentra has grown into a national partner for cooperative financial institutions and their members. The group’s leadership team is led by President and Chief Executive Officer Glenn Crawley, who oversees strategic direction and risk management for Concentra’s various business lines. With its cooperative structure and focus on partnership, Concentra continues to support the long-term resilience of Canada’s credit-union system.

Key Stats

• Today's Range: $22.90 to $23.75
• 50-Day Range: $19.49 to $23.78
• 52-Week Range: $18.89 to $24.77
• Volume: 1.18 million shs
• Average Volume: 958,641 shs
• Market Capitalization: $2.96 billion
• P/E Ratio: 19.41
• Dividend Yield: 1.08%
• Price Target: $27.50
• Consensus Rating: Buy

Concentra Group Holdings Parent Stock Analysis - MarketRank™

Concentra Group Holdings Parent scored higher than 52% of companies evaluated by MarketBeat, and ranked 563rd out of 928 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Buy

Consensus Rating

Concentra Group Holdings Parent has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Concentra Group Holdings Parent has a consensus price target of $27.50, representing about 19.0% upside from its current price of $23.10.

Amount of Analyst Coverage

Concentra Group Holdings Parent has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -11.56%

Earnings Growth

Earnings for Concentra Group Holdings Parent are expected to decrease by -11.56% in the coming year, from $1.47 to $1.30 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Concentra Group Holdings Parent is 19.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 278.13.

Price to Earnings Ratio vs. Sector

The P/E ratio of Concentra Group Holdings Parent is 19.41, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.29.

Price to Earnings Growth Ratio

Concentra Group Holdings Parent has a PEG Ratio of 2.11. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Concentra Group Holdings Parent has a P/B Ratio of 10.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CON.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Concentra Group Holdings Parent pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Concentra Group Holdings Parent does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Concentra Group Holdings Parent is 21.01%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Concentra Group Holdings Parent will have a dividend payout ratio of 19.23% next year. This indicates that Concentra Group Holdings Parent will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for CON.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.69

News Sentiment

Concentra Group Holdings Parent has a news sentiment score of 1.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Concentra Group Holdings Parent this week, compared to 5 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concentra Group Holdings Parent insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.60% of the stock of Concentra Group Holdings Parent is held by insiders.

CON Stock Analysis - Frequently Asked Questions

How have CON shares performed this year?

Concentra Group Holdings Parent's stock was trading at $19.78 at the start of the year. Since then, CON shares have increased by 16.8% and is now trading at $23.1030.

How were Concentra Group Holdings Parent's earnings last quarter?

Concentra Group Holdings Parent, Inc. (NYSE:CON) posted its quarterly earnings data on Thursday, August, 7th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.37. The company's quarterly revenue was up 15.2% on a year-over-year basis.
Read the conference call transcript.

When did Concentra Group Holdings Parent IPO?

Concentra Group Holdings Parent (CON) raised $529 million in an IPO on Thursday, July 25th 2024. The company issued 22,500,000 shares at $23.50 per share.

Who are Concentra Group Holdings Parent's major shareholders?

Concentra Group Holdings Parent's top institutional shareholders include State Street Corp (3.33%), JPMorgan Chase & Co. (2.68%), Geode Capital Management LLC (2.04%) and Thrivent Financial for Lutherans (1.79%).

How do I buy shares of Concentra Group Holdings Parent?

Shares of CON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concentra Group Holdings Parent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concentra Group Holdings Parent investors own include Skye Bioscience (SKYE), CervoMed (CRVO), Core Scientific (CORZ), ChargePoint (CHPT), Carnival Co. & (CCL), Carrier Global (CARR) and Bit Digital (BTBT).

Company Calendar

• Last Earnings: 8/07/2025
• Record date for 8/28 Dividend: 8/21/2025
• Ex-Dividend for 8/28 Dividend: 8/21/2025
• Dividend Payable: 8/28/2025
• Today: 9/07/2025
• Next Earnings (Estimated): 10/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CON
• Previous Symbol: NYSE:CON
• CIK: 2014596
• Web: N/A
• Phone: (717) 972-1100
• Fax: N/A
• Employees: 11,250
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Concentra Group Holdings Parent: $27.50
• High Price Target: $30.00
• Low Price Target: $25.00
• Potential Upside/Downside: +19.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.19
• Trailing P/E Ratio: 19.41
• Forward P/E Ratio: 15.72
• P/E Growth: 2.11
• Net Income: $166.54 million
• Net Margins: 7.44%
• Pretax Margin: 10.47%
• Return on Equity: 50.84%
• Return on Assets: 5.89%

Debt

• Debt-to-Equity Ratio: 4.75
• Current Ratio: 1.18
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $1.90 billion
• Price / Sales: 1.56
• Cash Flow: $1.85 per share
• Price / Cash Flow: 12.50
• Book Value: $2.20 per share
• Price / Book: 10.50

Miscellaneous

• Outstanding Shares: 128,170,000
• Free Float: 119,712,000
• Market Cap: $2.96 billion
• Optionable: N/A
• Beta: 0.98